Redux Echocardiographic Data Expected By Fall AHA Meeting - AHP
Executive Summary
One-year echocardiographic data from a placebo-controlled cohort study of regular and sustained-release dexfenfluramine will be available by September, American Home Products Senior VP-Science and Technology Robert Levy, MD, told an investor teleconference Aug. 10.